Review of the rebound phenomenon in new anticoagulant treatments
Authors:
- 23 January 2006
- journal article
- review article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 22 (3) , 471-481
Abstract
Background: The launch of new anticoagulant treatments has sparked debate as to the optimal drug to use for primary prevention of venous thromboembolism (VTE) in major orthopaedic surgery, for the treatment of VTE, and for stroke prevention in atrial fibrillation, taking into account both efficacy and tolerability. Newer drugs such as fondaparinux and ximelagatran have shown improvements in short-term efficacy or convenience, but such effects may be offset by reduced tolerability. They also raise the question of a possible delayed increase in thromboembolic events after these drugs are stopped, the so- called “rebound effect”.Objective: To review pharmacological and clinical data describing the rebound effect associated with new and standard anticoagulant drugs.Research design and methods: Computerized searches, covering the period 1960–2005 for the historical background and physiopathology review, and from 1999 to 2005 for the clinical trial analysis, were performed on BIOSIS, PubMed and clinical...Keywords
This publication has 46 references indexed in Scilit:
- The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS studyJournal of Thrombosis and Haemostasis, 2003
- The statin warsThe Lancet, 2003
- Comparison of Ximelagatran with Warfarin for the Prevention of Venous Thromboembolism after Total Knee ReplacementNew England Journal of Medicine, 2003
- Rebound after cessation of oral anticoagulant therapy: the biochemical evidenceBritish Journal of Haematology, 1996
- Importance of factor Xa in determining the procoagulant activity of whole-blood clots.Journal of Clinical Investigation, 1993
- Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectorisJACC, 1993
- Effect of cessation of anticoagulant therapy on the course of ischaemic heart disease.BMJ, 1966
- The Rebound Phenomenon-Fact or Fancy?Circulation, 1965
- Rebound Phenomena after Anticoagulant Therapy in Cerebrovascular DiseaseCirculation, 1963
- Long-term anticoagulant therapy in coronary atherosclerosisAmerican Heart Journal, 1958